Nakadate T, Suzuki M, Sato H
Gan. 1979 Aug;70(4):435-46.
A study was undertaken to investigate the mechanism of liberation of tumor cells into the blood stream in connection with the process of tumor growth, using three strains of ascites tumor such as Yoshida sarcoma (YS) with infiltrative growth pattern, AH100B with expansive one, and AH109A with intermediate one. For this experiment, a new method for the quantitation of the number of circulating tumor cells was devised. From its results, it was concluded as follows: (1) Tumor cells appear first in the circulating blood at the transitional phase from logarithmic growth to declining growth. (2) Tumor size is a macroscopical index of the risk of the liberation of tumor cells into the blood stream. (3) Tumor necrosis is a histological sign suggesting that the tumor growth phase is declining, namely, that hematogenous dissemination of tumor cells has begun already. (4) There is a striking difference in the frequency and number of tumor cells in the venous blood among these three tumor strains. The tumour strains in order of the number of the circulating tumor cells are YS, AH109A, and AH100B. (5) In YS and AH109A, the transition of the number of tumor cells liberated into the blood stream is closely related to the growth process of tumor tissue. (6) Liberated cells of AH109A and AH100B disappear promptly from the blood stream.
本研究采用三种腹水瘤株,即具有浸润性生长模式的吉田肉瘤(YS)、具有膨胀性生长模式的AH100B和具有中间型生长模式的AH109A,来研究肿瘤细胞在肿瘤生长过程中释放到血流中的机制。为此实验设计了一种定量循环肿瘤细胞数量的新方法。根据实验结果,得出以下结论:(1)肿瘤细胞在对数生长期向衰退期过渡阶段首次出现在循环血液中。(2)肿瘤大小是肿瘤细胞释放到血流中风险的宏观指标。(3)肿瘤坏死是一种组织学征象,提示肿瘤生长阶段正在衰退,即肿瘤细胞的血行播散已经开始。(4)这三种肿瘤株静脉血中肿瘤细胞的频率和数量存在显著差异。按循环肿瘤细胞数量排序的肿瘤株依次为YS、AH109A和AH100B。(5)在YS和AH109A中,释放到血流中的肿瘤细胞数量的转变与肿瘤组织的生长过程密切相关。(6)AH109A和AH100B的释放细胞迅速从血流中消失。